Virus roundup …  

    • Johnson & Johnson launched a 60,000-person clinical trial of its single-dose COVID-19 vaccine on three continents, becoming the fourth experimental shot to enter final-stage testing in the U.…

    Already an INSIDER? Sign in.

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.